CSIMarket Company Name, Ticker, Customers, else..


Charles River Laboratories International inc   (NYSE: CRL)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Charles River Laboratories International inc

CRL's Fundamental analysis



Charles River Laboratories International Inc 's sales fell by -2.71 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 1102

Medical Laboratories industry recorded growth of revenues by 2.95 %

Charles River Laboratories International Inc 's net profit decreased by -65.26 % in first quarter of 2025 year on year, to $26 millions.

• More on CRL's Growth


Charles River Laboratories International Inc
realized a net loss in trailing twelve months.

Charles River Laboratories International Inc realized cash reduction of $ -2.1 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.81.
Medical Laboratories industry's Price to Sales ratio is at 2.23.


• More on CRL's Valuation
 
 Total Debt (Millions $) 2,511
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 184,523
 Net Income/Employee (TTM) $ -1,069
 Receivable Turnover (TTM) 5.37
 Tangible Book Value (Per Share $) -6.47

Charles River Laboratories International Inc
realized net loss in trailing twelve months.

Charles River Laboratories International Inc realized cash outflow of $ -2.1per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 1.81.
Medical Laboratories industry's Price to Sales ratio is at 2.23.

Charles River Laboratories International Inc Price to Book Ratio is at 2.27 lower than Industry Avg. of 151.29. and higher than S&P 500 Avg. of 0.01

• More on CRL's Valuation

•  Market Capitalization (Millions $) 7,276
•  Shares Outstanding (Millions) 51
•  Employees 21,800
•  Revenues (TTM) (Millions $) 4,023
•  Net Income (TTM) (Millions $) -23
•  Cash Flow (TTM) (Millions $) -107
•  Capital Exp. (TTM) (Millions $) -213
•  Total Debt (Millions $) 2,511
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 184,523
•  Net Income/Employee(TTM) $ -1,069
•  Receivable Turnover Ratio (TTM) 5.37
•  Tangible Book Value (Per Share $) -6.47

•  Market Capitalization (Millions $) 7,276
•  Shares Outstanding (Millions) 51
•  Employees 21,800
•  Revenues (TTM) (Millions $) 4,023
•  Net Income (TTM) (Millions $) -23
•  Cash Flow (TTM) (Millions $) -107
•  Capital Exp. (TTM) (Millions $) -213


    CRL's Profitability Comparisons
Charles River Laboratories International Inc achieved increase in profitability, due to cost control. Operating Margin grew in first quarter of 2025 to 7.59 %.

Charles River Laboratories International Inc net profit margin of 2.63 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 123 in Healthcare sector and number 1439 in S&P 500.


Profitability by Segment
RMS 20.46 %
DSA 15.85 %
Total 2.63 %



  Ratio
•   Capital Ratio (MRQ) 1.88
•  Total Debt to Equity (MRQ) 0.78
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.52
•  Inventory Turnover Ratio (TTM) 7.2



Charles River Laboratories International Inc achieved increase in profitability, due to cost control. Operating Margin grew in first quarter of 2025 to 7.59 %.

Charles River Laboratories International Inc net profit margin of 2.63 % is currently ranking no. 9 in Medical Laboratories industry, ranking no. 123 in Healthcare sector and number 1439 in S&P 500.

• More on CRL's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com